FDA Approves Weight Loss Drug Zepbound, Joining Ozempic And Wegovy In Market

The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.

#news #fda #elililly

CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.

Subscribe to the CBS News YouTube channel: https://youtube.com/cbsnews
Watch CBS News: https://cbsn.ws/1PlLpZ7c
Download the CBS News app: https://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: https://facebook.com/cbsnews
Follow CBS News on Twitter: https://twitter.com/cbsnews
Subscribe to our newsletters: https://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com